Search for: "Mylan, Inc." Results 41 - 60 of 672
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Mar 2022, 7:39 am by Zak Gowen
  U.S. life sciences company Illumina’s offer to cut prices and allow rivals continued access to its technologies has “yet to convince” EU antitrust regulators scrutinizing its $8 billion cash-and-stock bid for Grail Inc, people familiar with the matter said. [read post]
1 Feb 2022, 1:22 pm by Dennis Crouch
Mylan Pharmaceuticals Inc., Docket No. 21-01729 (Fed. [read post]
25 Jan 2022, 8:13 am by Suzanne E. Durrell
EHR Company Athenahealth Settles Case for $18.25 Million in January 2021 Our first False Claims Act settlement of 2021 resolved allegations that athenahealth Inc. [read post]
4 Jan 2022, 6:00 am by Douglas J. Bucklin, Ph.D.
Cir. 2021) 2021-1729 AstraZeneca AB and AstracZeneca Pharmacueticals LP (AstraZeneca) sued Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. [read post]
9 Dec 2021, 7:15 am by Logan Murr
On December 8, the United States Court of Appeals for the Federal Circuit (CAFC), in a precedential decision authored by Judge Stoll, vacated a  judgment of infringement against Mylan Pharmaceuticals Inc. and affirmed the nonobvious determination of the United States District Court for the Northern District of West Virginia. [read post]
9 Dec 2021, 7:15 am by Logan Murr
On December 8, the United States Court of Appeals for the Federal Circuit (CAFC), in a precedential decision authored by Judge Stoll, vacated a  judgment of infringement against Mylan Pharmaceuticals Inc. and affirmed the nonobvious determination of the United States District Court for the Northern District of West Virginia. [read post]
8 Dec 2021, 8:52 am by Lawrence B. Ebert
The outcome AstraZeneca AB and AstraZeneca Pharmaceuticals LP (collectively, “AstraZeneca”) sued Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. [read post]
8 Nov 2021, 9:15 am by Steve Brachmann
Mylan Pharmaceuticals Inc. affirming a ruling of the District of Delaware, which dismissed a Hatch-Waxman lawsuit against related Mylan entities for either improper venue or failure to state a claim upon which relief could be granted. [read post]
8 Nov 2021, 9:15 am by Steve Brachmann
Mylan Pharmaceuticals Inc. affirming a ruling of the District of Delaware, which dismissed a Hatch-Waxman lawsuit against related Mylan entities for either improper venue or failure to state a claim upon which relief could be granted. [read post]